High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis

BACKGROUND: The systemic immune-inflammation index (SII) has emerged as a promising marker predicting the prognosis of some cancers, while its role in urothelial carcinoma (UC) remains uncertain, especially in upper urinary tract urothelial carcinoma (UTUC). This meta-analysis aimed to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wen, Zhang, Yixuan, Wang, Miaomiao, Wang, Miao, Yang, Qingya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646434/
https://www.ncbi.nlm.nih.gov/pubmed/38023187
http://dx.doi.org/10.3389/fonc.2023.1229349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646434/
https://www.ncbi.nlm.nih.gov/pubmed/38023187
http://dx.doi.org/10.3389/fonc.2023.1229349

Ejemplares similares